These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
436 related articles for article (PubMed ID: 17482921)
41. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails. Rosario DJ; Phillips JT; Chapple CR J Urol; 2007 Mar; 177(3):1047-51; discussion 1051. PubMed ID: 17296409 [TBL] [Abstract][Full Text] [Related]
42. Outcomes of 80 W KTP laser vaporization of the large prostate. Tugcu V; Tasci AI; Sahin S; Ordekci Y; Karakas OF; Zorluoglu F Urol Int; 2007; 79(4):316-20. PubMed ID: 18025849 [TBL] [Abstract][Full Text] [Related]
43. Cost-effectiveness of new treatments for benign prostatic hyperplasia: results of a randomized trial comparing the short-term cost-effectiveness of transurethral interstitial laser coagulation of the prostate, transurethral microwave thermotherapy and standard transurethral resection or incision of the prostate. Nørby B; Nielsen HV; Frimodt-Møller PC Scand J Urol Nephrol; 2002; 36(4):286-95. PubMed ID: 12201922 [TBL] [Abstract][Full Text] [Related]
44. Initial and superior experience with 30 minute TUMT. Tomera KM; Tomera FM; Clark WR Tech Urol; 2000 Dec; 6(4):276-7. PubMed ID: 11108565 [TBL] [Abstract][Full Text] [Related]
45. Long-term use of tamsulosin to treat lower urinary tract symptoms/benign prostatic hyperplasia. Schulman CC; Lock TM; Buzelin JM; Boeminghaus F; Stephenson TP; Talja M; J Urol; 2001 Oct; 166(4):1358-63. PubMed ID: 11547074 [TBL] [Abstract][Full Text] [Related]
46. Transurethral microwave thermotherapy: clinical results after 11 years of use. Vesely S; Knutson T; Dicuio M; Damber JE; Dahlstrand C J Endourol; 2005; 19(6):730-3. PubMed ID: 16053366 [TBL] [Abstract][Full Text] [Related]
47. Long-term study to assess the efficacy of tamsulosin in the control of symptoms and complications developed in patients with symptomatic benign prostatic hyperplasia (OMNICONTROL study): first-year follow-up report. Palacio A; Hernández C; Marqués A; Prats J; Espinosa FJ Arch Esp Urol; 2004 May; 57(4):451-60. PubMed ID: 15270291 [TBL] [Abstract][Full Text] [Related]
48. The resolution of detrusor over activity after medical and surgical treatment in patients with bladder outlet obstruction. Sriplakich S; Promwatcharanon K J Med Assoc Thai; 2007 Nov; 90(11):2326-31. PubMed ID: 18181315 [TBL] [Abstract][Full Text] [Related]
49. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study. Roehrborn CG; McVary KT; Elion-Mboussa A; Viktrup L J Urol; 2008 Oct; 180(4):1228-34. PubMed ID: 18722631 [TBL] [Abstract][Full Text] [Related]
50. Vaporesection for managing benign prostatic hyperplasia using a 2-microm continuous-wave laser: a prospective trial with 1-year follow-up. Fu WJ; Hong BF; Yang Y; Zhang X; Gao JP; Zhang L; Wang XX BJU Int; 2009 Feb; 103(3):352-6. PubMed ID: 18778340 [TBL] [Abstract][Full Text] [Related]
51. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study. Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352 [TBL] [Abstract][Full Text] [Related]
52. Transurethral ethanol injection therapy of benign prostatic hyperplasia: four-year follow-up. Sakr M; Eid A; Shoukry M; Fayed A Int J Urol; 2009 Feb; 16(2):196-201. PubMed ID: 19054163 [TBL] [Abstract][Full Text] [Related]
53. Long-term follow-up study to evaluate the efficacy and safety of the doxazosin gastrointestinal therapeutic system in patients with benign prostatic hyperplasia with or without concomitant hypertension. Chung BH; Hong SJ BJU Int; 2006 Jan; 97(1):90-5. PubMed ID: 16336335 [TBL] [Abstract][Full Text] [Related]
54. Transurethral microwave thermotherapy (Prostatron version 2.5) compared with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: a randomized, controlled, parallel study. Ahmed M; Bell T; Lawrence WT; Ward JP; Watson GM Br J Urol; 1997 Feb; 79(2):181-5. PubMed ID: 9052467 [TBL] [Abstract][Full Text] [Related]
55. [Experiences in the treatment of benign prostatic hyperplasia with high power potassium-titanyl-phosphate (KTP) laser]. Lipiński MI; Peszyński-Drews C; Jeromin MZ; Jeromin LM Wiad Lek; 2006; 59(3-4):196-8. PubMed ID: 16813263 [TBL] [Abstract][Full Text] [Related]
56. Transurethral microwave thermotherapy for management of benign prostatic hyperplasia: durability of response. Baba S; Nakamura K; Tachibana M; Murai M Urology; 1996 May; 47(5):664-71. PubMed ID: 8650863 [TBL] [Abstract][Full Text] [Related]
57. Long-term results of three different minimally invasive therapies for lower urinary tract symptoms due to benign prostatic hyperplasia: comparison at a single institute. Ohigashi T; Nakamura K; Nakashima J; Baba S; Murai M Int J Urol; 2007 Apr; 14(4):326-30. PubMed ID: 17470164 [TBL] [Abstract][Full Text] [Related]
58. A meta-analysis of trials of transurethral needle ablation for treating symptomatic benign prostatic hyperplasia. Boyle P; Robertson C; Vaughan ED; Fitzpatrick JM BJU Int; 2004 Jul; 94(1):83-8. PubMed ID: 15217437 [TBL] [Abstract][Full Text] [Related]
59. Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostate. Seki N; Yunoki T; Tomoda T; Takei M; Yamaguchi A; Naito S Neurourol Urodyn; 2008; 27(3):222-5. PubMed ID: 17580358 [TBL] [Abstract][Full Text] [Related]
60. Results of treatment with tamsulosin in men with acute urinary retention. Kim HL; Kim JC; Benson DA; Bales GT; Gerber GS Tech Urol; 2001 Dec; 7(4):256-60. PubMed ID: 11763483 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]